Objective The main aim of this study was to explore the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in the treatment of adolescents with attention deficit/hyperactivity disorder (ADHD). Methods Seventeen adolescents aged 11-18 years, diagnosed with ADHD, par
โฆ LIBER โฆ
Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study
โ Scribed by Karen C. Wells; Jeffery N. Epstein; Stephen P. Hinshaw; C. Keith Conners; John Klaric; Howard B. Abikoff; Ann Abramowitz; L. Eugene Arnold; Glenn Elliott; Laurence L. Greenhill; Lily Hechtman; Betsy Hoza; Peter S. Jensen; John S. March; William Pelham; Linda Pfiffner; Joanne Severe; James M. Swanson; Benedetto Vitiello; Tim Wigal
- Book ID
- 110220304
- Publisher
- Springer US
- Year
- 2000
- Tongue
- English
- Weight
- 63 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0091-0627
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Duloxetine in the treatment of adolescen
โ
Javad Mahmoudi-Gharaei; Nasrin Dodangi; Mehdi Tehrani-Doost; Toktam Faghihi
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 2 views
Association analysis of the monoamine ox
โ
Katharina Domschke; Karen Sheehan; Naomi Lowe; Aiveen Kirley; Celine Mullins; Ro
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 68 KB
๐ 3 views